<DOC>
	<DOCNO>NCT00130481</DOCNO>
	<brief_summary>The purpose study determine Atorvastatin improve blood vessel stiffness blood vessel function child 10-18 year old Type 1 Type 2 diabetes . Subjects receive atorvastatin 20mg placebo daily 3 month switch therapy next 3 month . Hypothesis : Atorvastatin improve blood vessel function decrease arterial stiffness improve blood flow .</brief_summary>
	<brief_title>Pediatric Atorvastatin Diabetes Intervention Trial ( PADIT )</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<criteria>Type 1 Diabetes Mellitus ( T1DM ) Type 2 Diabetes Mellitus ( T2DM ) 1 year Age 1018 year . Cardiovascular disease ( CVD ) Liver disease Pregnancy Use cholesterol triglyceride lower drug Perceived inability comply study protocol Endocrinopathy diabetes</criteria>
	<gender>All</gender>
	<minimum_age>10 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>Diabetes</keyword>
	<keyword>Children</keyword>
	<keyword>Adolescents</keyword>
	<keyword>Arterial Compliance</keyword>
	<keyword>Physiology Cardiovascular Endothelium</keyword>
</DOC>